Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac extracellular matrix (ECM) is a complex, dynamic, and highly organized network of proteins and polysaccharides that fills the space between cells in the heart. It provides both structural support and biochemical signals essential for heart development, function, homeostasis, and response to injury. Alterations in composition or organization of the cardiac ECM are central features in many cardiovascular diseases. Targeting specific ECM components or their regulatory enzymes is an area of therapeutic interest for modulating adverse remodeling after injury. The ECM is not merely a passive scaffold but an active participant in regulating cellular functions critical for normal heart physiology as well as pathophysiological responses following stress or damage. Its intricate composition allows it to serve both mechanical roles—preserving organ integrity—and dynamic regulatory functions essential for adaptation throughout life.
Modulation of ECM remodeling via MMP or TIMP inhibition; alteration of collagen crosslinking; inhibition of fibrosis signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac Extracellular Matrix (Cardiac ECM).